These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16508168)

  • 1. Determination of p-glycoprotein ATPase activity using luciferase.
    Matsunaga T; Kose E; Yasuda S; Ise H; Ikeda U; Ohmori S
    Biol Pharm Bull; 2006 Mar; 29(3):560-4. PubMed ID: 16508168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.
    Bucher K; Besse CA; Kamau SW; Wunderli-Allenspach H; Krämer SD
    Pharm Res; 2005 Mar; 22(3):449-57. PubMed ID: 15835751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes.
    Kamiyama E; Nakai D; Mikkaichi T; Okudaira N; Okazaki O
    Life Sci; 2010 Jan; 86(1-2):52-8. PubMed ID: 19914261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form.
    Rebbeor JF; Senior AE
    Biochim Biophys Acta; 1998 Feb; 1369(1):85-93. PubMed ID: 9528676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells.
    Sugawara T; Kinoshita M; Ohnishi M; Tsuzuki T; Miyazawa T; Nagata J; Hirata T; Saito M
    Biosci Biotechnol Biochem; 2004 Dec; 68(12):2541-6. PubMed ID: 15618625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
    Hosoya KI; Kim KJ; Lee VH
    Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of mitragynine on P-glycoprotein in vitro.
    Rusli N; Amanah A; Kaur G; Adenan MI; Sulaiman SF; Wahab HA; Tan ML
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):481-496. PubMed ID: 30604191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein in the transport of tanshinone I, one active triterpenoid from Salvia miltiorrhiza.
    Li XX; Zhou ZW; Zhou SF
    Drug Metab Lett; 2008 Aug; 2(3):223-30. PubMed ID: 19356097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence.
    Rothnie A; Theron D; Soceneantu L; Martin C; Traikia M; Berridge G; Higgins CF; Devaux PF; Callaghan R
    Eur Biophys J; 2001 Oct; 30(6):430-42. PubMed ID: 11718296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-operating ATP sites in the multiple drug resistance transporter Mdr1.
    Buxbaum E
    Eur J Biochem; 1999 Oct; 265(1):54-63. PubMed ID: 10491157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells.
    Takara K; Tsujimoto M; Ohnishi N; Yokoyama T
    Biochem Biophys Res Commun; 2002 Mar; 292(1):190-4. PubMed ID: 11890691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse.
    Petropoulos S; Gibb W; Matthews SG
    Placenta; 2010 Sep; 31(9):803-10. PubMed ID: 20655586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
    Cavet ME; West M; Simmons NL
    Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells.
    Taur JS; DesJardins CS; Schuck EL; Wong YN
    Xenobiotica; 2011 Apr; 41(4):320-6. PubMed ID: 21162698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.